The latest immunotherapy news and developments
Scientists at St. Jude Children’s Research Hospital, USA, identified a molecular mechanism that in a preclinical study…
Advances in cellular immunotherapy that spur genetically modified T cells to attack cancer cells have…
Collaboration between pharmaceutical companies and the Center for Computational Imaging and Personalised Diagnostics (CCIPD) at Case…
Male sex hormones interfere with the body’s ability to fight bladder cancer, likely explaining why…
A blood-based tumour biomarker can predict the benefit of immunotherapy to patients with non-small cell…
T cells are usually very good at eliminating diseased cells. But they seem to fail…
In a Phase II clinical trial, immune checkpoint blockade before surgery was associated with favourable…
Immunotherapy has had limited success so far against glioblastoma, the most common and aggressive form…
Recent research led by MD Anderson identified associations between neoadjuvant immune checkpoint blockade responses and B…
Mount Sinai researchers have validated for the first time that a simple blood test called…